Evidence map›Paper›PMID 17654530›Full record

ArticleThe Prostate2007

High resolution oligonucleotide CGH using DNA from archived prostate tissue.

Pamela L Paris, Shivaranjani Sridharan, Alicia Scheffer, Anya Tsalenko, Laurakay Bruhn, Colin Collins

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in The Prostate, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. The zinc finger transcription factor ZKSCAN3 promotes prostate cancer cell migration.The international journal of biochemistry & cell biology · 2012
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Pamela L ParisDepartment of Urology, Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California 94143, USA.
Shivaranjani Sridharan
Alicia Scheffer
Anya Tsalenko
Laurakay Bruhn
Colin Collins
Agilent Technologies (United States) · USUCSF Helen Diller Family Comprehensive Cancer Center · US

Funding

UCSF PROSTATE CANCER SPOREP50CA089520 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CARROLL, PETER R · 2000 to 2008
$13.9M
NCI NIH HHS P50 CA089520NCI NIH HHS P50CA89520
6 · The paper itself

Abstract

backgroundThe current focus on biomarker discovery is a result of an improved understanding of the biological basis for carcinogenesis and advances in technology. Biomarkers can aid in diagnosis, prognosis, treatment selection, and drug development. There is an urgent need for high-resolution tools that perform well using archived tissue for biomarker discovery and tools that can translate into the clinic.

methodsOligonucleotide array comparative genomic hybridization (oCGH) was compared to BAC-based aCGH using unamplified total genomic DNA from formalin fixed paraffin-embedded (FFPE) prostate tissue.

resultsThe copy number aberrations detected with the BAC and oligonucleotide arrays were highly correlated in cases where the arrays contained probes in similar genomic locations. The oligonucleotide array platform provided more precise mapping due to the higher density of oligonucleotide probes.

conclusionsThese results demonstrate the utility of high-resolution oligonucleotide arrays designed to use genomic DNA for CGH measurements using archived tissue samples for discovery and clinic based assays.

Indexed as

Chromosome AberrationsChromosome MappingChromosomes, Artificial, BacterialDNA, NeoplasmGenomicsHumansMaleNucleic Acid HybridizationOligonucleotide Array Sequence AnalysisProstatic NeoplasmsDNA, Neoplasm

Identifiers

PMID17654530
PMCPMC2844769
OpenAlexW2077224297

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.